BHV-7000

· Biohaven Therapeutics Ltd.

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for BHV-7000, covering 2025-12-16 to 2026-08-13. Get the full timeline:

Most recent: Clinical Trial Update: Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy [Phase 2, Phase 3]

See pricing